Class 4 Caution in use-Clobazam suspension 5mg/5ml & 10mg/5ml

Atnahs Pharma UK Ltd has informed the MHRA that the batches of Clobazam Atnahs 5mg/5ml and 10mg/5ml Oral Suspension listed in this notification do not contain the most up to date safety information.

MHRA drug alert date: 13th December 2023

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-atnahs-pharma-uk-limited-clobazam-atnahs-5mg-slash-5ml-and-10mg-slash-5ml-oral-suspension-el-23-a-slash-43?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=d9cfeb7b-3172-4a81-9b19-60e910ea91a1&utm_content=immediately

This is a caution in use only we are not accepting stock returns

Further Information

For more information, or medical information queries, please contact +44 (0) 1268 943 700, and for stock control queries, please contact +44 (0) 1268 943 700.

UK Minister for Public Health visits Alcura

We were delighted to welcome the The Minister for Public Health, Start for Life and Primary Care, the Rt Hon Andrea Leadsom MP to Alcura’s Brackmills site to show her the fantastic work our Northampton team are doing.

The minister was given a full tour of the site by Alcura’s Head of Production, Ellie Taylor, and saw first-hand the vital role our staff play in the medicine supply chain.

The minster then sat down with Alliance Healthcare’s Marie Evans, Owen Cooper, Sam Unsworth and Catherine Van Vilet to discuss the key challenges the sector faces and the incredible work of Alcura’s home care offering. 

Thank you to everyone involved in the visit and a special thanks to the Alcura Northampton Team for all of your hard work. 

Class 4 caution in use- Clarithromycin 250mg and 500mg

Strandhaven Limited t/a Somex Pharma has informed the MHRA regarding an error with the Patient Information Leaflets (PILs) that have been packed in the listed batches of Clarithromycin 250mg and 500mg film-coated tablets.

MHRA drug alert date: 6th December 2023

MHRA drug alert link:  https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-strandhaven-ltd-t-slash-a-somex-pharma-clarithromycin-250mg-and-500mg-film-coated-tablets-el-23-a-slash-42

This is a caution in use only we are not accepting stock returns

Further Information

For more information, medical information queries, contact: regulatory@somexpharma.com, tel: 020 8590 9399, choose option 3 or 4.

For stock control queries, contact: accounts@somexpharma.com, tel: 020 8590 9399, choose option 2.

Class 4 caution in use- Tramadol 50mg capsules

Strandhaven Limited t/a Somex Pharma has informed the MHRA regarding an error with the Patient Information Leaflets (PILs) that have been packed in the listed batches of Tramadol Hydrochloride 50mg Capsules, Hard

MHRA drug alert date: 6th December 2023

MHRA drug alert link:https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-strandhaven-ltd-t-slash-a-somex-pharma-tramadol-hydrochloride-50mg-capsules-hard-el-23-a-slash-41?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=58cc3b9b-942b-448f-8503-aaeab8d73d7d&utm_content=immediately

This is a caution in use only we are not accepting stock returns

Further Information

For more information, medical information queries, contact: regulatory@somexpharma.com, tel: 020 8590 9399, choose option 3 or 4.

For stock control queries, contact: accounts@somexpharma.com, tel: 020 8590 9399, choose option 2.

Class 4 caution in use-Caramet 25/100mg CR Tablet

Teva UK Limited, the Marketing Authorisation Holder (MAH) has informed the MHRA of a labelling error for the batch listed in this notification

MHRA drug alert date: 4th December 2023

MHRA drug alert link:  https://www.gov.uk/drug-device-alerts/class-4-medicines-notification-teva-uk-ltd-dot-caramet-25-slash-100mg-cr-tablets-el-23-a-slash-40?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=fb44128a-df16-4382-837c-9ec3a1412da8&utm_content=immediately

This is a caution in use only we are not accepting stock returns

Further Information

For medical information queries, please contact Teva UK Limited Medical Information via phone on 0207 540 7117 or via email medinfo@tevauk.com.

For stock control queries, please contact Teva UK Limited Customer Solutions via phone on 0800 590502 or via email customer.services@tevauk.com.

Christmas 2023 and New Year Opening Hours

To help keep our customers informed of changes to our service, we have published our bank holiday opening hours for the 2023 Christmas and New Year period.

View our bank holiday opening hours:

Alliance Healthcare Christmas 2023 and New Year Opening Hours

Alliance Healthcare Christmas 2023 and New Year Opening Hours for Channel Islands and Isle of Man

Alcura Homecare Christmas 2023 and New Year Opening Hours

Class 3 recall-Fluenz Tetra nasal spray suspension.

AstraZeneca UK Ltd. has informed the MHRA of an issue related to the expiry dates for certain batches of Fluenz Tetra. This recall provides further advice on the safe use of the product up to the amended expiry date.

MHRA Drug alert link: https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-astrazeneca-uk-ltd-dot-fluenz-tetra-nasal-spray-suspension-el-23-a-slash-39?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=7d47971e-3b90-4324-907c-33274035a69c&utm_content=immediately

Further information

For medical information enquiries please contact AstraZeneca Medical Information medical.informationUK@astrazeneca.com or call 0800 783 0033.

Fluenz Tetra remains available to order by NHS providers of the children’s flu programme in England and Wales via the ImmForm website (Helpdesk: 0207 183 8580 or Helpdesk@immform.org.uk).

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Customer level recall-Specific brands of carbomer eye gel

Specific batches of carbomer gel are being recalled as a precaution due to possible microbiological contamination.

MHRA Drug alert link:

https://www.gov.uk/drug-device-alerts/specific-brands-of-carbomer-eye-gel-recall-of-aacarb-eye-gel-aacomer-eye-gel-and-puroptics-eye-gel-potential-risk-of-infection-dsi-slash-2023-slash-11?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=c596e044-f42d-4f51-8f4f-16dc07374147&utm_content=immediately

·  

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

World Antimicrobial Awareness Week 2023: Alliance Healthcare UK and Alphega Pharmacy Reiterate Their Commitment

Alliance Healthcare UK and Alphega Pharmacy are once more rallying behind World Antimicrobial Awareness Week (WAAW) this year. This marks a continuation of their support from the previous year, as they aim to tackle the global challenge of Antimicrobial Resistance (AMR).

The theme for WAAW 2023 is "Preventing Antimicrobial Resistance Together”. This decision was made after a comprehensive online consultation by the World Health Organisation, with stakeholders spanning human, animal, plant, and environmental health sectors in search of an impactful campaign theme.

This year's WAAW runs from the 18th till the 25th of November. The week-long initiative aspires to raise awareness about global antimicrobial resistance (AMR), driving best practices regarding antimicrobial usage to curtail the emergence and spread of drug-resistant infections.

Marie Evans, Managing Director, Alliance Healthcare said: “We are once again proud to be supporting AMR week to increase awareness of global antimicrobial resistance (AMR) and to encourage best practices for using antimicrobials. It is important to continue to share awareness of this and pledge our support along with the NHS.”

The campaign alerts people that unnecessary intake of antibiotics could lead them towards having more serious or prolonged infections and strongly encourages adherence to doctor’s advice on antibiotic use.

Support us and the NHS during World Antimicrobial Awareness Week

Alliance Healthcare continues its pledge to be an Antibiotic Guardian and is proud to support this campaign once more. Find out more here.

Alliance Healthcare UK and Alphega Pharmacy UK support Pharmacist Support’s ACTNow campaign

Alliance Healthcare UK and Alphega Pharmacy UK are once again proudly supporting Pharmacist Support’s ACTNow campaign.

The campaign supports pharmacists and pharmacy teams to encourage a mental health and wellbeing culture shift in the workplace, this year’s focus is to highlight real life workplace wellbeing practices that have made a positive impact.

ACTnow encourages individuals to:

• - Allow time for wellbeing
• - Consider the needs of others
• - Take action

In 2022, the ACTNow campaign achieved remarkable milestones, with a 49% increase in sign-ups and a 197% rise in social media engagement compared to the previous year. The campaign garnered over 16,000 website page views, reached a broader audience, including more male pharmacists, and received overwhelming positive feedback, with 88% of participants finding it very useful or useful, and 85% expressing the desire for future campaigns.

To find out more about the ACTNow Campaign please click here.